Apatinib-induced protective autophagy and apoptosis through the AKT–mTOR pathway in anaplastic thyroid cancer
2018 · Cell Death and Disease · 131 citations
https://doi.org/10.1038/s41419-018-1054-3
X
Xi Cheng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
162
Papers
2.8K
Citations
31
h-index
70
i10-index
Xi Cheng is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Colorectal Cancer Surgical Treatments & Corneal surgery and disorders. The author has an h-index of 31, co-authored 138 publications.
ORCID: 0000-0002-0009-8189Papers by this author
worksTargeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer
2020 · Cell Death and Disease · 72 citations
https://doi.org/10.1038/s41419-020-03111-7
A positive feedback loop of β-catenin/CCR2 axis promotes regorafenib resistance in colorectal cancer
2019 · Cell Death and Disease · 34 citations
https://doi.org/10.1038/s41419-019-1906-5
FGFR3△7–9 promotes tumor progression via the phosphorylation and destabilization of ten-eleven translocation-2 in human hepatocellular carcinoma
2020 · Cell Death and Disease · 24 citations
https://doi.org/10.1038/s41419-020-03089-2
The role of E26 transformation-specific variant transcription factor 5 in colorectal cancer cell proliferation and cell cycle progression
2021 · Cell Death and Disease · 18 citations
https://doi.org/10.1038/s41419-021-03717-5
Single-incision robotic assisted surgery: a nonrandomized cohort pilot study on a novel surgical platform in colorectal surgery
2023 · International Journal of Surgery · 16 citations
https://doi.org/10.1097/js9.0000000000000612
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat